on Immunic AG
Immunic to Participate in Industry and Scientific Conferences in June
NEW YORK, May 28, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in key conferences in June.
From June 3-6, Immunic will attend the BIO International Convention 2024. Jessica Breu, Vice President of Investor Relations and Communications, will present on June 4 in San Diego. The presentation can be accessed via Immunic’s website. Management and investor relations teams will engage in partnering activities through the conference's portal.
Immunic will also participate in the Pharmaceutical Contract Management Group (PCMG) Assembly 2024 in Den Haag from June 5-7. Werner Gladdines, Vice President of Program Management & Clinical Development Operations, will join a panel discussion on June 6.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Immunic AG news